The aim of this project is to take advantage of major recent advances in knowledge of the structure-function relationships of plasma lipoproteins to characterize, in women, biological processes that are likely to predispose to coronary disease or to confer protection against it. Such knowledge, by identifying new risk factors, could lead to early identification of individuals at high risk and could also provide the basis for novel strategies of treatment designed to mitigate processes that contribute to atherogenesis, or to enhance those that are protective. Whereas ultracentrifugation appears to derange the native architecture of high density lipoproteins (HDL), a newly developed strategy of non- denaturing immunosorption permits the separation of seven to eight discrete species. Quantitative profiles of these newly discovered species will be measured in two hundred reproductive age and postmenopausal women. Functional roles of the individual species will be studied with respect to the transfer of cholesteryl esters to acceptor lipoproteins, a step critical to the cholesterol retrieval pathway. Deficient transfer of cholesteryl esters to low density lipoproteins (LDL) by HDL may underlie the phenomenon of hyperdense LDL, related in some studies to risk of coronary disease. This project will explore the relationship of HDL species distribution to this phenomenon. Oxidation of LDL may be critical to the development of arteriosclerotic heart disease. Significant inhibition of the process by HDL has been demonstrated. An objective of this study is the identification of all the HDL species responsible for this antioxidant effect and the mechanisms by which they act.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL050782-01
Application #
2227075
Study Section
Special Emphasis Panel (ZHL1-CSR-C (S1))
Project Start
1994-04-01
Project End
1998-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Kane, John P; Malloy, Mary J (2012) Prebeta-1 HDL and coronary heart disease. Curr Opin Lipidol 23:367-71
Guey, Lin T; Pullinger, Clive R; Ishida, Brian Y et al. (2011) Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. Am J Cardiol 108:360-6
Engler, Mary B; Pullinger, Clive R; Malloy, Mary J et al. (2008) Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia. Metabolism 57:1719-24
Wung, Shu-Fen; Kulkarni, Medha V; Pullinger, Clive R et al. (2006) The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion. Lipids Health Dis 5:19
Aouizerat, Bradley E; Engler, Mary B; Natanzon, Yanina et al. (2006) Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia. J Lipid Res 47:787-93
Albert, Timothy S E; Duchateau, Philippe N; Deeb, Samir S et al. (2005) Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL. J Lipid Res 46:469-74
Aouizerat, Bradley E; Kulkarni, Medha; Heilbron, David et al. (2003) Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 44:1167-73
Wung, Shu-Fen; Aouizerat, Bradley E (2003) Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics. Res Theory Nurs Pract 17:281-99; discussion 335-8
Pullinger, Clive R; Eng, Celeste; Salen, Gerald et al. (2002) Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110:109-17
Duchateau, P N; Movsesyan, I; Yamashita, S et al. (2000) Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J Lipid Res 41:1231-6

Showing the most recent 10 out of 17 publications